Buzzy “Highly Recommended” In National Injection Guidelines
Non-adherence is a significant problem in medical management. New national guidelines recommend Buzzy Pain Relief.
May 17, 2018
Media Coverage
MMJ Labs receives patent for pain control and increased blood flow
We have been broadening our base of pain relief therapeutics to incorporate improved blood flow and venous access, based on research showing our Buzzy® device improves phlebotomy success
May 11, 2016
510K FDA Clearance Press Release
Atlanta, GA – MMJ Labs LLC, the world leader in non-invasive reusable pain relief devices, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)
January 7, 2016